A

Active Director Director DIN 08623571
DIN 08623571 First appointment Nov 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Astha

Data last updated:

Astha is a Director at Humannovo Health Care Private Limited (since 2024) and Director at Humannovo Life Science Private Limited (since 2019). The companies operate in Chemicals.

DIN 08623571
Primary Designation Director
Industry Chemicals
First Appointment 27 Nov 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Dec 20242024Active
Director27 Nov 20192019Active

Directorship timeline

Open interactive timeline →
Humannovo Life Science Private Limited
Humannovo Health Care Private Limited
Premium access

Shareholding and investment profile for Astha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Astha

Astha currently holds 2 directorships: Humannovo Health Care Private Limited (Director, since 02 Dec 2024); Humannovo Life Science Private Limited (Director, since 27 Nov 2019).

Astha was first appointed on 27 Nov 2019 as Director at Humannovo Life Science Private Limited. The most recent appointment on record is 02 Dec 2024 at Humannovo Health Care Private Limited.

The current boards of Astha's companies include Sumit Kumar Kesarwani (Humannovo Health Care Private Limited), Babli Devi (Humannovo Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available